StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note issued to investors on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Shares of NASDAQ ATHX opened at $0.01 on Friday. The stock has a market cap of $833,206.50, a PE ratio of -0.01 and a beta of -0.90. Athersys has a 12-month low of $0.01 and a 12-month high of $1.99.
About Athersys
See Also
- Five stocks we like better than Athersys
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Find and Profitably Trade Stocks at 52-Week Lows
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- 3 Monster Growth Stocks to Buy Now
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
